Differences in Clinical Manifestations among Cryptosporidium Species and Subtypes in HIV‐Infected Persons
1Division of Parasitic Diseases, National Center for Zoonotic, Vector‐Borne and Enteric Diseases, US Centers for Disease Control and Prevention, Atlanta, and 2University of Georgia, Griffin; 3Johns Hopkins University, Baltimore, Maryland; 4Asociacion Benéfica PRISMA, 5Hospital Arzobispo Loayza, and 6Hospital Dos de Mayo, Lima, Peru
We performed a cross‐sectional study to determine the epidemiology of Cryptosporidium in human immunodeficiency virus (HIV)–infected persons at 3 diagnostic levels: microscopy, genotypes of Cryptosporidium, and subtype families of C. hominis and C. parvum. The study enrolled 2490 HIV‐infected persons in Lima, Peru, and 230 were microscopy positive for Cryptosporidium infection. Specimens from 193 participants were available for genotyping. They had C. hominis (141 persons), C. parvum (22 persons), C. meleagridis (17 persons), C. canis (6 persons), C. felis (6 persons), and C. suis (1 person) infection. Although microscopy results showed that Cryptosporidium infections were associated with diarrhea, only infections with C. canis, C. felis, and subtype family Id of C. hominis were associated with diarrhea, and infection with C. parvum was associated with chronic diarrhea and vomiting. These results demonstrate that different Cryptosporidium genotypes and subtype families are linked to different clinical manifestations.
Received 10 October 2006; accepted 15 March 2007; electronically published 13 July 2007.
Cited by
Online publication date: 1-Feb-2009.
CrossRef
Online publication date: 1-Jan-2009.
CrossRef
Online publication date: 1-Dec-2008.
CrossRef
Online publication date: 1-Jul-2008.
CrossRef
Online publication date: 1-May-2008.
CrossRef
-
Potential conflicts of interest: none reported.
Financial support: Opportunistic Infections Working Group of the Centers for Disease Control and Prevention (CDC); RG‐ER Fund; National Institute for Allergy and Infectious Disease, National Institutes of Health (projects 5P01AI051976‐04 and 5R21AI059661‐02 to R.H.G. and V.A.C.); Division of Parasitic Diseases, CDC (Research Participation Program appointment to S.C. administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and the CDC).
The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.





